Cargando…

Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate

The CRISPR system provides adaptive immunity against mobile genetic elements in prokaryotes, utilising small CRISPR RNAs which direct effector complexes to degrade invading nucleic acids1–3. Type III effector complexes were recently demonstrated to synthesise a novel second messenger, cyclic oligoad...

Descripción completa

Detalles Bibliográficos
Autores principales: Athukoralage, Januka S, Rouillon, Christophe, Graham, Shirley, Grüschow, Sabine, White, Malcolm F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219705/
https://www.ncbi.nlm.nih.gov/pubmed/30232454
http://dx.doi.org/10.1038/s41586-018-0557-5
_version_ 1783368701036199936
author Athukoralage, Januka S
Rouillon, Christophe
Graham, Shirley
Grüschow, Sabine
White, Malcolm F
author_facet Athukoralage, Januka S
Rouillon, Christophe
Graham, Shirley
Grüschow, Sabine
White, Malcolm F
author_sort Athukoralage, Januka S
collection PubMed
description The CRISPR system provides adaptive immunity against mobile genetic elements in prokaryotes, utilising small CRISPR RNAs which direct effector complexes to degrade invading nucleic acids1–3. Type III effector complexes were recently demonstrated to synthesise a novel second messenger, cyclic oligoadenylate (cOA), on binding target RNA4,5. cOA in turn binds to and activates ribonucleases and other factors via a CARF (CRISPR associated Rossman Fold) domain, inducing an antiviral state in the cell that is important for immunity. The mechanism of the “off-switch” that resets the system is not understood. Here, we report the identification of the nuclease that degrades these cOA ring molecules. The “Ring nuclease” is itself a CARF family protein with a metal independent mechanism, which cleaves cA(4) rings to generate linear di-adenylate species and switches off the antiviral state. The identification of Ring nucleases adds an important insight to the CRISPR system.
format Online
Article
Text
id pubmed-6219705
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-62197052019-03-19 Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate Athukoralage, Januka S Rouillon, Christophe Graham, Shirley Grüschow, Sabine White, Malcolm F Nature Article The CRISPR system provides adaptive immunity against mobile genetic elements in prokaryotes, utilising small CRISPR RNAs which direct effector complexes to degrade invading nucleic acids1–3. Type III effector complexes were recently demonstrated to synthesise a novel second messenger, cyclic oligoadenylate (cOA), on binding target RNA4,5. cOA in turn binds to and activates ribonucleases and other factors via a CARF (CRISPR associated Rossman Fold) domain, inducing an antiviral state in the cell that is important for immunity. The mechanism of the “off-switch” that resets the system is not understood. Here, we report the identification of the nuclease that degrades these cOA ring molecules. The “Ring nuclease” is itself a CARF family protein with a metal independent mechanism, which cleaves cA(4) rings to generate linear di-adenylate species and switches off the antiviral state. The identification of Ring nucleases adds an important insight to the CRISPR system. 2018-09-19 2018-10 /pmc/articles/PMC6219705/ /pubmed/30232454 http://dx.doi.org/10.1038/s41586-018-0557-5 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Athukoralage, Januka S
Rouillon, Christophe
Graham, Shirley
Grüschow, Sabine
White, Malcolm F
Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
title Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
title_full Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
title_fullStr Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
title_full_unstemmed Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
title_short Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
title_sort ring nucleases deactivate type iii crispr ribonucleases by degrading cyclic oligoadenylate
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219705/
https://www.ncbi.nlm.nih.gov/pubmed/30232454
http://dx.doi.org/10.1038/s41586-018-0557-5
work_keys_str_mv AT athukoralagejanukas ringnucleasesdeactivatetypeiiicrisprribonucleasesbydegradingcyclicoligoadenylate
AT rouillonchristophe ringnucleasesdeactivatetypeiiicrisprribonucleasesbydegradingcyclicoligoadenylate
AT grahamshirley ringnucleasesdeactivatetypeiiicrisprribonucleasesbydegradingcyclicoligoadenylate
AT gruschowsabine ringnucleasesdeactivatetypeiiicrisprribonucleasesbydegradingcyclicoligoadenylate
AT whitemalcolmf ringnucleasesdeactivatetypeiiicrisprribonucleasesbydegradingcyclicoligoadenylate